Seldon Capital’s Healthpeak Properties DOC Stock Holding History

Seldon Capital’s Portfolio DOC Stock Details DOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-757	Closed	-$19K	–	105
2022 Q4	$19K	Hold	757	–	–	0.02%	205
2022 Q3	$17K	Hold	757	–	–	0.01%	214
2022 Q2	$20K	Hold	757	–	–	0.01%	217
2022 Q1	$26K	Hold	757	–	–	0.02%	209
2021 Q4	$27K	Buy	+757	New	+$26.1K	0.02%	214

Other funds holding DOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Resolution Capital Sydney, NSW, Australia $5.44B AUM 27.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Seldon Capital's DOC Position: Q1 2023 in Review

Seldon Capital sold out of Healthpeak Properties (DOC) in Q1 2023, closing a stake of 757 shares — an estimated $19K sold.

Seldon Capital first reported a position in DOC in Q4 2021 and held it in 5 quarters. The position peaked at $27K in Q4 2021. 592 funds tracked by Wall St. Rank hold DOC as of Q1 2023.

Seldon Capital reported no remaining Healthpeak Properties position as of Q1 2023 after selling out during the quarter.
Seldon Capital sold 757 Healthpeak Properties shares in Q1 2023, an estimated $19K.
Seldon Capital first reported a position in Healthpeak Properties in Q4 2021 and held it in 5 quarters.
Seldon Capital's Healthpeak Properties position peaked at $27K in Q4 2021.
592 funds tracked by Wall St. Rank held Healthpeak Properties as of Q1 2023.

Based on Seldon Capital's 13F filing for Q1 2023, filed 12 May 2023.